When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Adenomyosis

Last reviewed: 25 Feb 2025
Last updated: 13 Mar 2025

Summary

Definition

History and exam

Key diagnostic factors

  • dysmenorrhea
  • menorrhagia
  • enlarged, globular, tender uterus
  • dyspareunia
  • chronic pelvic pain
Full details

Other diagnostic factors

  • subfertility or adverse pregnancy outcomes
  • genitourinary or gastrointestinal pressure symptoms
Full details

Risk factors

  • reproductive age group
  • gravidity and parity
  • early menarche
  • endometriosis
  • endometrial hyperplasia
  • uterine leiomyoma
  • black or Hispanic ethnicity
  • short menstrual cycle
  • spontaneous and induced abortion
  • past uterine surgery
  • use of tamoxifen
  • obesity
Full details

Diagnostic tests

1st tests to order

  • ultrasound (US)
Full details

Tests to consider

  • MRI
  • histologic diagnosis following hysterectomy
  • hysterosalpingography (HSG)
Full details

Emerging tests

  • fertility-sparing biopsy techniques

Treatment algorithm

ONGOING

future fertility desired

future fertility not desired

Contributors

Authors

Gaby Moawad, MD, FACOG

Clinical Associate Professor of Obstetrics and Gynecology

The George Washington University School of Medicine & Health Sciences

Washington

DC

Founder

The Center for Endometriosis & Advanced Pelvic Surgery (CEAPS)

McLean

VA

Disclosures

GM has received payment from Intuitive for speaking at conferences.

Youssef Youssef, MD, FACOG

Minimally Invasive Gynecology fellow

Maimonides Medical Center

Brooklyn

New York

NY

Disclosures

YY declares that he has no competing interests.

Peer reviewers

Elizabeth A. Stewart, MD

Professor of Obstetrics and Gynecology Consultant

Division of Reproductive Endocrinology

Department of Obstetrics and Gynecology

Mayo Clinic

Professor of Obstetrics and Gynecology

Mayo Clinic College of Medicine and Science

Rochester

MN

Disclosures

EAS has received grants for her institution from the Agency for Healthcare Research and Quality/Patient-Centered Outcome Research and the Eunice Kennedy Shriver Institute of Child Health and Human Development of the National Institutes of Health; has received consulting fees from AbbVie and Anylyn; holds a patent for Methods and Compounds for Treatment of Abnormal Uterine Bleeding, which has no commercial activity; has received royalties from UpToDate; has received fees for developing educational content from the MED-IQ, Physicians' Education Resource, Omnia Education, Omnicuris, and WebMD; and serves as an unpaid advisor to The Fibroid Foundation and as unpaid treasurer of the International Gynecologic Society.

Meenu Priyadarshini Nanthakumar, MBBS, DNB(OG), MRCOG

ST6 Obstetrics and Gynaecology

Worcestershire Acute Hospitals NHS Trust

Worcestershire

UK

Disclosures

MPN declares that she has no competing interests.

Janesh Gupta, MSc, MD, FRCOG

Honorary Professor of Obstetrics and Gynaecology

Birmingham Women's and Children's Hospital

Birmingham

UK

Disclosures

JG declares that he has no competing interests.

  • Adenomyosis images
  • Differentials

    • Leiomyomas (fibroids)
    • Endometriosis
    • Endometrial hyperplasia
    More Differentials
  • Guidelines

    • SOGC guideline no. 437: diagnosis and management of adenomyosis
    • ACOG practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women
    More Guidelines
  • Patient information

    Painful periods

    Fertility problems: questions to ask your doctor

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer